ArticleCommunications biology2025

Intranasally administrated fusion-inhibitory lipopeptides block SARS-CoV-2 infection in mice and enable long-term protective immunity.

Said Mougari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.